as of 11-10-2026 12:03pm EST
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. The company generated $3.5 billion in revenue in 2025.
| Founded: | 1987 | Country: | United States |
| Employees: | N/A | City: | NORTHBROOK |
| Market Cap: | 17.6B | IPO Year: | 1994 |
| Target Price: | $262.93 | AVG Volume (30 days): | 750.4K |
| Analyst Decision: | Buy | Number of Analysts: | 15 |
| Dividend Yield: | Dividend Payout Frequency: | quarterly | |
| EPS: | 5.49 | EPS Growth: | -3.46 |
| 52 Week Low/High: | $160.60 - $243.80 | Next Earning Date: | 10-28-2026 |
| Revenue: | $3,457,500,000 | Revenue Growth: | 5.77% |
| Revenue Growth (this year): | 7.7% | Revenue Growth (next year): | 6.15% |
| P/E Ratio: | 42.95 | Index: | |
| Free Cash Flow: | 616.8M | FCF Growth: | +14.21% |
SVP, GC, CAO & Corp Sec
Avg Cost/Share
$238.59
Shares
385
Total Value
$91,859.04
Owned After
4,327
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Anderson Lisa M | IEX | SVP, GC, CAO & Corp Sec | Aug 12, 2026 | Sell | $238.59 | 385 | $91,859.04 | 4,327 |
SEC 8-K filings with transcript text
Oct 28, 2026 · 100% conf.
1D
-1.90%
$232.64
Act: +0.33%
5D
-2.66%
$230.83
20D
-1.18%
$234.35
2 iex-20260930xex991.htm
Document
For further information: TRADED: NYSE (IEX) EX-99.1
Investor Contact:
Jim Giannakouros, CFA
Vice President, Investor Relations
(847) 313-9506
Third Quarter Highlights
(All comparisons are against the prior year period unless otherwise noted)
•Record sales of $952 million increased 8% on both a reported and organic basis
•Reported diluted EPS of $1.95 and record adjusted diluted EPS of $2.33 both increased 15%
•Orders of $991 million increased 13% on both a reported and organic basis
•Strategic acquisitions gaining momentum through higher-value applications in advantaged markets
•Returned $129 million to shareholders through dividends and share repurchases
NORTHBROOK, IL, October 28, 2026 - IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended September 30, 2026.
“We are pleased to report another strong quarter, with results ahead of our expectations. This quarter, we delivered both record sales and adjusted EPS while expanding margins and booked nearly $1 billion in orders. Advantaged markets and larger acquired businesses are driving this performance, and momentum is broadening across the rest of the portfolio,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President.
“Our teams continued to execute well as we met our customers’ increasing demand and drove strong incremental margins on the increased volume. Our ability to drive margin expansion during a period of continued inflation demonstrates the strength of our team and the power of 8020. Additionally, 8020 drives each business toward its full potential and provides the right framework for allocating resources and technologies toward the most attractive opportunities for sustainable value creation across IDEX.”
“We are again increasing our full-year financial guidance due to our strong performance year-to-date, with improved visibility and momentum as we close out 2026.”
Outlook(1)
•Full year organic sales projected to increase 6.5% to 6.8% over the prior year, up from previous guidance of 5% to 6%
•Full year adjusted diluted EPS of $8.91 to $8.96, up approximately 12% year-over-year at midpoint, up from previous guidance of $8.70 to $8.85
(1) The Company does not reconcile its forward-looking non-GAAP measures to the most directly comparable financial measures calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) because the timing and magnitude of certain items, including future foreign exchange impacts, acquisitions, divestitures, restructuring costs, impairments, tax impacts, and other special items, cannot be reasonably estimated at this time without unreasonable effort. The unavailable information could have a significant impact on U.S. GAAP results.
Consolidated Financial Results
Three Months Ended September 30,
(Dollars in millions, except per share amounts)20262025Increase (Decrease)
U.S. GAAP Results
Orders$991.2$880.3$110.9
Change in reported orders 13%
Net sales951.7878.773.0
Change in reported net sales 8%
Gross profit429.5390.638.9
Gross margin45.1%44.5%60 bps
Net income attributable to IDEX144.1127.816.3
Net income margin15.1%14.5%60 bps
Diluted EPS attributable to IDEX1.951.700.25
Cash flows from operating activities239.5203.536.0
Operating cash flow as a percent of net income166%159% NM
Non-GAAP Results*
Change in organic orders 13%
Change in organic sales 8%
Adjusted gross profit430.3391.239.1
Adjusted gross margin45.2%44.5%70 bps
Adjusted net income attributable to IDEX 172.8152.820.0
Adjusted EBITDA 264.8239.825.0
Adjusted EBITDA margin 27.8%27.3%50 bps
Adjusted diluted EPS attributable to IDEX 2.332.030.30
Free cash flow 214.3188.725.6
Free cash flow conversion 124%123%100 bps
NM – Not Meaningful
*Each of the items below is a non-GAAP measure. See the definitions of these non-GAAP measures in the section in this release titled “Non-GAAP Measures of Financial Performance” and reconciliations to their most directly comparable GAAP financial measures in the reconciliation tables at the end of this release.
•Net sales increased primarily as a result of increased organic sales. The increase in organic sales was driven by higher volumes, primarily in our Health & Science Technologies (“HST”) segment, and positive price across the segments.
•Gross margin and Adjusted gross margin both increased due to volume leverage, net productivity improvements and favorable mix. These increases were partially offset by price/cost headwinds. Adjusted gross margin excludes the impact of restructuring-related charges, consisting primarily of accelerated depreciation related to the anticipated closure of a facility in the HST segment.
•Both Diluted EPS and Adjusted diluted EPS increased, primarily due to improved operational results discussed above.
Jul 29, 2026 · 100% conf.
1D
+1.00%
$227.38
Act: +1.85%
5D
+2.95%
$231.77
20D
+2.97%
$231.81
2 iex-20260630xex991.htm
Document
For further information: TRADED: NYSE (IEX) EX-99.1
Investor Contact:
Jim Giannakouros, CFA
Vice President, Investor Relations
(847) 313-9506
Highlights
(All comparisons are against the prior year period unless otherwise noted)
•Record sales of $921 million increased 6% on a reported basis and 5% organically
•Reported diluted EPS of $1.93 increased 11% and record adjusted diluted EPS of $2.32 increased 12%
•Record orders of over $1 billion increased 29% on a reported basis and 28% organically
•Returned capital to shareholders via $77 million of share repurchases and $54 million of dividends
•Raising full year 2026 organic growth and adjusted EPS guidance ranges
NORTHBROOK, IL, July 29, 2026 - IDEX Corporation (NYSE: IEX) today announced its financial results for the three-month period ended June 30, 2026.
“We are very pleased to see continued results momentum as our IDEX teams drove another quarter of strong sales and earnings growth. Orders of over $1 billion in the quarter were a record as we continue to see elevated demand across the advantaged markets where we’ve focused our investments and capabilities,” said Eric D. Ashleman, IDEX Corporation Chief Executive Officer and President.
“Our teams executed exceptionally well, as flow-through on strong volume drove earnings above our expectations, demonstrating the benefits of the work already completed to strengthen the quality of our businesses. We continue to advance 8020 initiatives to both fuel higher growth and unlock further margin expansion opportunities across IDEX.”
“We are increasing our full-year financial guidance expectations due to our strong performance year-to-date and improved visibility in the second half of our fiscal year.”
Outlook(1)
•Full year organic sales projected to increase 5% to 6% over the prior year, up from previous guidance of 3% to 4%
•Full year adjusted diluted EPS of $8.70 to $8.85, up approximately 10% year-over-year at midpoint, up from previous guidance of $8.35 to $8.55
•Third quarter 2026 organic sales projected to increase 5% to 7% from the prior year period
•Third quarter 2026 adjusted diluted EPS of $2.20 to $2.25
(1) The Company does not reconcile its forward-looking non-GAAP measures to the most directly comparable U.S. GAAP financial measure because the timing and magnitude of certain items, including future foreign exchange impacts, acquisitions, divestitures, restructuring costs, impairments, tax impacts, and other special items, cannot be reasonably estimated at this time without unreasonable effort. The unavailable information could have a significant impact on GAAP results.
Consolidated Financial Results
Three Months Ended June 30,
(Dollars in millions, except per share amounts)20262025Increase (Decrease)
U.S. GAAP Results
Orders$1,071.6$829.8$241.8
Change in reported orders 29%
Net sales920.6865.455.2
Change in reported net sales 6%
Gross profit426.8392.234.6
Gross margin46.3%45.3%100 bps
Net income attributable to IDEX143.4131.611.8
Net income margin15.6%15.1%50 bps
Diluted EPS attributable to IDEX1.931.740.19
Cash flows from operating activities200.0161.738.3
Operating cash flow as a percent of net income140%123% NM
Non-GAAP Results*
Change in organic orders 28%
Change in organic sales 5%
Adjusted gross profit427.3392.235.1
Adjusted gross margin46.4%45.3%110 bps
Adjusted net income attributable to IDEX 172.4156.515.9
Adjusted EBITDA 258.3237.221.1
Adjusted EBITDA margin 28.1%27.4%70 bps
Adjusted diluted EPS attributable to IDEX 2.322.070.25
Free cash flow 177.0146.930.1
Free cash flow conversion 103%94% NM
NM – Not Meaningful
*Each of these items below are non-GAAP measures. See the definitions of these non-GAAP measures in the section in this release titled “Non-GAAP Measures of Financial Performance” and reconciliations to their most directly comparable GAAP financial measures in the reconciliation tables at the end of this release.
•Net sales increased primarily as a result of increased organic sales, as well as contributions from acquisitions. The increase in organic sales was primarily driven by higher volumes in our Health & Science Technologies (“HST”) segment and positive price. Net sales included a $14.7 million reduction resulting from expected customer rebates associated with refunds for tariffs under the International Emergency Economic Powers Act (“IEEPA”) that were subsequently invalidated.
•Gross margin and Adjusted gross margin both increased due to net productivity improvements, volume leverage and positive price/cost. Positive price/cost was driven by the net benefit of IEEPA tariff refunds, which contributed 150 basis points to both measures, and more than offset a challenging prior year price/cost comparison. These increases were partially offset by unfavorable mix. Adjusted gross margin excludes restructuring-re
Apr 29, 2026 · 100% conf.
1D
+1.11%
$219.75
Act: +0.23%
5D
+3.31%
$224.54
Act: +0.39%
20D
+3.87%
$225.75
Act: -3.36%
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.c706d217.1784334245.cce14fc5
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
See how IEX stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "IEX IDEX Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.